Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS Ruminococcus gnavus ATCC 29149

ABSTRACT: This study investigates the growth of Ruminococcus gnavus strain ATCC 29149 under two different conditions over a period of 3 hours. The experimental conditions include: RG (Ruminococcus gnavus in Meat Broth): R. gnavus grown in standard meat broth. RS-SA (Ruminococcus gnavus in Meat Broth with Sialic Acid): R. gnavus grown in meat broth supplemented with sialic acid. Control conditions were also established for comparison: CT (Control in Meat Broth): Standard meat broth without R. gnavus. CT-SA (Control in Meat Broth with Sialic Acid): Meat broth with sialic acid, also without R. gnavus.

INSTRUMENT(S): Q Exactive Plus

ORGANISM(S): Ruminococcus Gnavus Atcc 29149 (ncbitaxon:411470)

SUBMITTER: Nan Gao

PROVIDER: MSV000095089 | GNPS | Thu Jun 20 06:30:00 BST 2024

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS Ruminococcus gnavus Strains

Project description:Strains of Ruminococcus gnavus, specifically ATCC 29149, ATCC 35913, H2-28, and Mediterraneibacter gnavus AGR 2154 (previously known as Ruminococcus gnavus), were cultured under three different conditions: Meat Broth (CNTRL) Meat Broth with Sialic Acid (SIALIC) Meat Broth with 1% Porcine Mucin (PORCINE) The cultures were incubated for 3 hours. Following incubation, the spent media of the strains underwent polar metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) in negative ion mode.

2024-06-20 | MSV000095090 | GNPS

GNPS Ruminococcus gnavus Strains

Project description:Strains of Ruminococcus gnavus, specifically ATCC 29149 and ATCC 35913, as well as Mediterraneibacter gnavus H2-28 and AGR 2154 (formerly known as Ruminococcus gnavus), were cultured under three different conditions: Meat Broth (CTRL) Meat Broth with Sialic Acid (SIALIC) Meat Broth with 1% Porcine Mucin (PORCINE) The cultures were incubated for 3 hours. Following incubation, the spent media from each strain underwent polar metabolite analysis using liquid chromatography-mass spectrometry (LC-MS) in positive ion mode.

2024-06-20 | MSV000095093 | GNPS

Effect of agarooligosaccharide on gene expression of Ruminococcus gnavus

Project description:We performed a transcriptome analysis of Ruminococcus gnavus with and without 0.1% (w/w) agarooligosaccharide exposure to validate the mechanism of growth inhibition.

2023-12-31 | GSE243872 | GEO

Mediterraneibacter gnavus

Project description:Ruminococcus gnavus

| PRJNA388337 | ENA

Lack of TREM2 during anti-PD-1 therapy reprograms intestinal macrophages and microbiota to enhance tumor rejection

Project description:The gut microbiota and tumor-associated macrophages (TAM) impact anti-PD-1 checkpoint blockade. Reprogramming TAM by either blocking or deleting the macrophage receptor TREM2 attenuates tumor growth, and lack of functional TREM2 enhances tumor elimination by anti-PD-1. Here, we found that anti-PD-1 combined with TREM2 deficiency induces proinflammatory programs in intestinal macrophages and a concomitant expansion of Ruminococcus gnavus (R. gnavus) in the gut microbiota. Gavage of wild-type mice with R. gnavus recapitulated enhancement of anti-PD-1-mediated tumor elimination occurring in the absence of TREM2. The intestinal proinflammatory environment coincided with expansion, increased circulation and migration of TNF-producing CD4+ T cells to the tumor bed. Thus, TREM2 remotely controls anti-PD-1 checkpoint blockade through modulation of the intestinal immune environment and microbiota, with R. gnavus emerging as a potential probiotic agent for increasing responsiveness to anti-PD-1.

2024-05-17 | GSE262811 | GEO

Colon gene expression signatures in mice mono-associated with IBD-associated micro-organisms

Project description:Studying host-microbiota interactions is fundamental to understand mechanisms involved in intestinal inflammation and inflammatory bowel diseases. In this work, we studied these interactions in mice mono-associated with 4 bacteria and 2 yeasts, all representative of intestinal microbiota and/or associated with IBD pathogenesis: Bacteroides thetaiotaomicron, adhesive-invasive Escherichia coli (AIEC), Ruminococcus gnavus, Roseburia intestinalis, Saccharomyces boulardii and Candida albicans. Transcriptomics analyses showed that B. thetaiotaomicron had the highest immunological effect, being able to almost recapitulate the effects of a whole microbiota, and particularly induced Treg pathways. Furthermore, this analysis also pointed out the effects of E. coli AIEC LF82 on IDO activation and of S. boulardii on angiogenesis, as well as major effects of R. gnavus on metabolism. This work therefore reveals information on the role of each micro-organism and proposes several tracks to follow to better understand IBD pathogenesis and identify therapeutic targets 6 mono-associations + 2 controls (germ-free and conventionalized mice), with 5 to 7 mice per group.

2015-08-22 | E-GEOD-63299 | biostudies-arrayexpress

Mediterraneibacter gnavus CAG:126

Project description:Ruminococcus gnavus CAG:126 overview

| PRJNA207147 | ENA

WT vs KO of lp_2991 comparison

Project description:A mutant of L. plantarumWCFS1 (deletion of lp_2991) was compared with the wildtype grown in standard MRS broth. Cells were sampled at OD1 for mRNA extraction.

2010-04-01 | GSE20515 | GEO

The Effects of Bacillus licheniformis-fermented Products on Chronic Feline Diarrhea and Intestinal Microbiota

Project description:Bacillus licheniformis-fermented products (BLFP) are probiotics with antibacterial, antiviral, and anti-inflammatory properties that can improve growth performance. This study aimed to, firstly, compare the fecal microbiota of cats with chronic diarrhea (n = 8) with that of healthy cats (n = 4) from the same household using next-generation sequencing and, secondly, evaluate the effectiveness of oral administration of BLFP in relieving clinical signs and altering the intestinal microbiota in diarrheal cats. Six out of eight cats with diarrhea showed clinical improvement after BLFP administration for 7 days, and in two cats the stool condition was normal. A higher Firmicutes/Bacteroidetes ratio was noted in the feces of diarrheal cats without clinical improvement as compared with those in the healthy control group and in the diarrheal cats with clinical improvement after receiving BLFP. The phylum Bacteroidetes and class Bacteroidia decreased significantly in diarrheal cats regardless of BLFP administration. Blautia spp., Ruminococcus torques, and Ruminococcus gnavus, which belong to the Clostridium cluster XIVa and have been reported as beneficial to intestinal health, increased significantly in feces after BLFP treatment. Furthermore, a significant decrease in Clostridium perfringens was noted in diarrheal cats after BLFP administration. Overall, BLFP could be a potential probiotic to relieve gastrointestinal symptoms and improve fecal microbiota in cats with chronic diarrhea.

2022-08-24 | GSE203254 | GEO

Mediterraneibacter gnavus E1 strain:E1

Project description:Ruminococcus gnavus E1 Genome sequencing project

| PRJNA61033 | ENA